Fundz

Globus Medical

Audubon, Pennsylvania, United States · Biotechnology, Health Care, Manufacturing · 2,967 employees

Globus Medical, Inc. is a leading global musculoskeletal company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies.

Recent signals

  • Jun 03, 2026: SEC 8-K (5.02): On June 3, 2026, Globus Medical, Inc. held its 2026 Annual Meeting of Stockholders where the stockholders approved an amendment to the 2021 Equity Incentive Plan, increasing the number of shares authorized by 1,000,000. This amendment was previously recommended by the Compensation Committee and approved by the Board of Directors, contingent on stockholder approval. The approval of this amendment enhances the Company’s ability to incentivize and retain key employees, which could positively impact its operational performance and growth strategies moving forward.
  • Mar 23, 2026: SEC 8-K (5.02): On March 23, 2026, John A. DeFord, Ph.D., a member of the Board of Directors of Globus Medical, Inc., resigned from his position effective immediately. His resignation was not due to any disagreements with the company, indicating a smooth transition. The decision was communicated through a press release issued by the Company on the same date. This change in the Board may have implications for the company's governance and strategic decisions moving forward.
  • Feb 25, 2026: Acquired Globus Medical completes acquisition of Nevro
  • Feb 24, 2026: SEC 8-K (2.02): On February 24, 2026, Globus Medical, Inc. released its sales and operating results for the three and twelve-month periods ended December 31, 2025. This report highlights the financial performance of the company, including total sales figures, net income, and other key operational metrics. The press release provides valuable insights into the company's performance in the previous fiscal year, indicating trends that could affect investor perspectives and business strategies moving forward. This event is significant as it informs shareholders of the company's financial health and operational success.
  • Apr 03, 2025: Acquired Globus Medical completes acquisition of Nevro Corp.
  • Mar 11, 2025: Launched Globus Medical, Inc. launches the COHERE™ ALIF Spacer and Modulus™ ALIF Blades, enhancing anterior interbody surgical procedures.
  • Nov 22, 2024: Launched Globus Medical, Inc. Launches ExcelsiusHub™ Navigation System to Enhance Spine Surgery Precision.
  • Feb 05, 2024: Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer

See plans & pricing → Track Globus Medical’s funding, hiring, and signals — with verified contacts — on Fundz.